These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [The pharmacological effect of betapressin in hypertension].
    Author: Zaslavskaia RM, Akhmetov KZh, Gol'denberg VA, Lilitsa GV.
    Journal: Eksp Klin Farmakol; 1996; 59(6):23-5. PubMed ID: 9181866.
    Abstract:
    The work analyses the results of treating 20 hypertensive patients with (stage I-II) with betapressin. The drug is shown to be active in causing a significant decrease of systolic and mean arterial pressure. Its hypotensive effect is associated with essential decrease of peripheral vascular resistance. This circumstance, as well as acceleration of the heart rhythm, leads to increase of the cardiac output. Betapressin is recommended for monotherapy of patients suffering from stages I-II hypertension with eu- and hypokinetic types of hemodynamics.
    [Abstract] [Full Text] [Related] [New Search]